Portfolio Holdings Detail for ISIN IE00BMX0DF60
Stock Name / Fund iShares US Medical Devices UCITS ETF
Issuer Blackrock
Entity holding fund iShares V Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF Ticker UMDV.AS(USD) CXE
ETF Ticker UMDV(USD) Euronext Amsterdam

Holdings detail for IART

Stock Name	Integra LifeSciences Holdings
Ticker	IART(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US4579852082
LEI	WB7IJCYY8YFTENS4O147

Show aggregate IART holdings

News associated with IART

Integra LifeSciences Holdings Corporation (NASDAQ:IART) Receives $18.63 Consensus Target Price from Analysts: Shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART – Get Free Report) have received an average recommendation of “Reduce” from the nine ratings firms that are covering the firm, Marketbeat Ratings reports. Four research analysts have rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating […] - 2025-08-06 02:14:54
Integra LifeSciences (NASDAQ:IART) Shares Up 8.8% on Better-Than-Expected Earnings: Shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART – Get Free Report) traded up 8.8% during trading on Thursday following a better than expected earnings announcement. The company traded as high as $14.07 and last traded at $13.46. 362,656 shares were traded during trading, a decline of 62% from the average session volume of 964,277 shares. […] - 2025-08-01 03:10:52
Victory Capital Management Inc. Acquires 135,308 Shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART): Victory Capital Management Inc. raised its holdings in Integra LifeSciences Holdings Corporation (NASDAQ:IART – Free Report) by 1,067.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 147,982 shares of the life sciences company’s stock after buying an additional 135,308 shares during the quarter. […] - 2025-07-28 05:16:52
Bank of New York Mellon Corp Sells 30,447 Shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART): Bank of New York Mellon Corp decreased its stake in Integra LifeSciences Holdings Corporation (NASDAQ:IART – Free Report) by 6.5% in the 1st quarter, Holdings Channel.com reports. The fund owned 437,515 shares of the life sciences company’s stock after selling 30,447 shares during the quarter. Bank of New York Mellon Corp’s holdings in Integra LifeSciences […] - 2025-07-22 06:22:52
11,425 Shares in Integra LifeSciences Holdings Corporation (NASDAQ:IART) Acquired by Wealth Enhancement Advisory Services LLC: Wealth Enhancement Advisory Services LLC acquired a new position in Integra LifeSciences Holdings Corporation (NASDAQ:IART – Free Report) in the 1st quarter, Holdings Channel reports. The firm acquired 11,425 shares of the life sciences company’s stock, valued at approximately $251,000. Other hedge funds also recently added to or reduced their stakes in the company. Assenagon […] - 2025-07-10 04:14:55
Integra LifeSciences Holdings Co. (NASDAQ:IART) Receives $18.63 Consensus PT from Analysts: Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report) have been assigned a consensus rating of “Reduce” from the nine brokerages that are currently covering the company, Marketbeat Ratings reports. Four investment analysts have rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy […] - 2025-06-17 02:49:03
Analyzing Integra LifeSciences (NASDAQ:IART) and Arch Therapeutics (OTCMKTS:ARTH): Arch Therapeutics (OTCMKTS:ARTH – Get Free Report) and Integra LifeSciences (NASDAQ:IART – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations. Volatility and Risk Arch Therapeutics has a […] - 2025-06-16 02:40:44
Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Sold by Squarepoint Ops LLC: Squarepoint Ops LLC decreased its position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 71.8% during the fourth quarter, Holdings Channel.com reports. The firm owned 25,285 shares of the life sciences company’s stock after selling 64,458 shares during the period. Squarepoint Ops LLC’s holdings in Integra LifeSciences were worth $573,000 as […] - 2025-06-04 05:48:48
75,900 Shares in Integra LifeSciences Holdings Co. (NASDAQ:IART) Bought by Universal Beteiligungs und Servicegesellschaft mbH: Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) during the 4th quarter, Holdings Channel.com reports. The firm purchased 75,900 shares of the life sciences company’s stock, valued at approximately $1,721,000. Other hedge funds and other institutional investors have also recently bought and sold […] - 2025-06-03 05:34:56
BNP Paribas Financial Markets Has $333,000 Position in Integra LifeSciences Holdings Co. (NASDAQ:IART): BNP Paribas Financial Markets cut its stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 86.9% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 14,690 shares of the life sciences company’s stock after selling 97,085 shares during the period. BNP Paribas Financial […] - 2025-05-27 06:12:44
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Buys 1,437 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART): MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 3.9% in the 4th quarter, Holdings Channel reports. The institutional investor owned 38,466 shares of the life sciences company’s stock after buying an additional 1,437 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS […] - 2025-05-27 04:47:03
Financial Review: Integra LifeSciences (NASDAQ:IART) and Vivos (OTCMKTS:RDGL): Integra LifeSciences (NASDAQ:IART – Get Free Report) and Vivos (OTCMKTS:RDGL – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership and earnings. Profitability This table compares Integra LifeSciences and Vivos’ […] - 2025-05-26 02:20:55
Brokerages Set Integra LifeSciences Holdings Co. (NASDAQ:IART) Price Target at $18.63: Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report) have been given an average recommendation of “Reduce” by the nine analysts that are currently covering the company, MarketBeat Ratings reports. Four research analysts have rated the stock with a sell recommendation, three have assigned a hold recommendation and two have issued a buy […] - 2025-05-23 02:48:54
Integra LifeSciences (NASDAQ:IART) Hits New 12-Month Low Following Weak Earnings: Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report) hit a new 52-week low during mid-day trading on Tuesday after the company announced weaker than expected quarterly earnings. The company traded as low as $11.60 and last traded at $13.28, with a volume of 7492449 shares trading hands. The stock had previously closed […] - 2025-05-07 03:10:42
Head to Head Review: Integra LifeSciences (NASDAQ:IART) & Venus Concept (NASDAQ:VERO): Venus Concept (NASDAQ:VERO – Get Free Report) and Integra LifeSciences (NASDAQ:IART – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, earnings, valuation, profitability and analyst recommendations. Analyst Recommendations This is a breakdown of […] - 2025-05-06 02:46:55
Integra LifeSciences (NASDAQ:IART) Shares Gap Down Following Weak Earnings: Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report) gapped down before the market opened on Monday following a dissappointing earnings announcement. The stock had previously closed at $16.85, but opened at $14.73. Integra LifeSciences shares last traded at $11.88, with a volume of 1,189,112 shares traded. The life sciences company reported $0.41 […] - 2025-05-06 02:10:50
Integra LifeSciences Holdings Co. (NASDAQ:IART) Receives $22.71 Consensus PT from Analysts: Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report) has earned an average recommendation of “Reduce” from the nine ratings firms that are covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the […] - 2025-04-28 02:24:43
Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Purchased by Sterling Capital Management LLC: Sterling Capital Management LLC boosted its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 821.7% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 2,166 shares of the life sciences company’s stock after purchasing an additional 1,931 shares during the period. Sterling Capital Management LLC’s […] - 2025-04-24 05:46:54
Legal & General Group Plc Has $4.91 Million Stock Position in Integra LifeSciences Holdings Co. (NASDAQ:IART): Legal & General Group Plc lessened its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 6.9% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 216,507 shares of the life sciences company’s stock after selling 16,109 shares during the quarter. Legal & […] - 2025-04-22 04:44:49
Sei Investments Co. Decreases Stock Position in Integra LifeSciences Holdings Co. (NASDAQ:IART): Sei Investments Co. trimmed its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 19.0% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 18,953 shares of the life sciences company’s stock after selling 4,448 shares during the period. Sei Investments Co.’s holdings in Integra LifeSciences were worth $430,000 at the […] - 2025-04-10 04:24:49
Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Sold by Vanguard Group Inc.: Vanguard Group Inc. trimmed its holdings in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 2.1% in the fourth quarter, HoldingsChannel reports. The firm owned 7,580,967 shares of the life sciences company’s stock after selling 162,961 shares during the period. Vanguard Group Inc. owned approximately 0.10% of Integra LifeSciences worth $171,936,000 at […] - 2025-04-07 04:41:00
Integra LifeSciences (NASDAQ:IART) Raised to Buy at Argus: Integra LifeSciences (NASDAQ:IART – Get Free Report) was upgraded by equities research analysts at Argus from a “hold” rating to a “buy” rating in a report released on Monday, MarketBeat Ratings reports. Separately, Morgan Stanley assumed coverage on shares of Integra LifeSciences in a research report on Monday, December 2nd. They issued an “underweight” rating […] - 2025-04-02 03:12:48
Quantbot Technologies LP Has $179,000 Stock Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART): Quantbot Technologies LP lowered its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 89.1% during the fourth quarter, HoldingsChannel.com reports. The firm owned 7,881 shares of the life sciences company’s stock after selling 64,470 shares during the period. Quantbot Technologies LP’s holdings in Integra LifeSciences were worth $179,000 at the end of […] - 2025-03-31 04:39:00
Intech Investment Management LLC Acquires 11,174 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART): Intech Investment Management LLC raised its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 86.4% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 24,113 shares of the life sciences company’s stock after acquiring an additional 11,174 shares during the period. Intech Investment Management LLC’s holdings in Integra LifeSciences were worth […] - 2025-03-25 07:08:55
PNC Financial Services Group Inc. Grows Stake in Integra LifeSciences Holdings Co. (NASDAQ:IART): PNC Financial Services Group Inc. lifted its stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 33.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 19,755 shares of the life sciences company’s stock after purchasing an additional […] - 2025-03-20 05:57:04
Integra LifeSciences Holdings Co. (NASDAQ:IART) Holdings Lowered by Bank of New York Mellon Corp: Bank of New York Mellon Corp cut its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 3.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 467,962 shares of the life sciences company’s stock after selling 15,830 shares […] - 2025-03-14 05:05:06
Amalgamated Bank Sells 478 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART): Amalgamated Bank reduced its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 2.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,394 shares of the life sciences company’s stock after selling 478 shares during the quarter. Amalgamated Bank’s holdings […] - 2025-03-05 08:26:53
Yousif Capital Management LLC Sells 906 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART): Yousif Capital Management LLC decreased its position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 3.4% in the 4th quarter, HoldingsChannel reports. The firm owned 25,762 shares of the life sciences company’s stock after selling 906 shares during the quarter. Yousif Capital Management LLC’s holdings in Integra LifeSciences were worth $584,000 […] - 2025-02-17 06:42:58

iShares US Medical Devices UCITS ETF IART holdings

Date	Number of IART Shares Held	Base Market Value of IART Shares	Local Market Value of IART Shares	Change in IART Base Value	Current Price per IART Share Held	Previous Price per IART Share Held
2025-12-03 (Wednesday)	9,275	USD 125,120	USD 125,120	USD 3,061	USD 13.49	USD 13.16
2025-12-02 (Tuesday)	9,275	USD 122,059	USD 122,059	USD 927	USD 13.16	USD 13.0601
2025-12-01 (Monday)	9,275	USD 121,132	USD 121,132	USD -556	USD 13.0601	USD 13.12
2025-11-28 (Friday)	9,275	USD 121,688	USD 121,688	USD 0	USD 13.12	USD 13.12
2025-11-27 (Thursday)	9,275	USD 121,688	USD 121,688	USD 0	USD 13.12	USD 13.12
2025-11-26 (Wednesday)	9,275	USD 121,688	USD 121,688	USD -1,206	USD 13.12	USD 13.25
2025-11-25 (Tuesday)	9,275	USD 122,894	USD 122,894	USD 7,142	USD 13.25	USD 12.48
2025-11-24 (Monday)	9,275	USD 115,752	USD 115,752	USD 4,081	USD 12.48	USD 12.04
2025-11-21 (Friday)	9,275	USD 111,671	USD 111,671	USD 9,182	USD 12.04	USD 11.05
2025-11-20 (Thursday)	9,275	USD 102,489	USD 102,489	USD -927	USD 11.05	USD 11.15
2025-11-19 (Wednesday)	9,275	USD 103,416	USD 103,416	USD -2,505	USD 11.15	USD 11.4201
2025-11-18 (Tuesday)	9,275	USD 105,921	USD 105,921	USD -2,875	USD 11.4201	USD 11.73
2025-11-17 (Monday)	9,275	USD 108,796	USD 108,796	USD -185	USD 11.73	USD 11.75

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of IART by Blackrock for IE00BMX0DF60

Show aggregate share trades of IART

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-06 SELL -160 11.330 11.010 11.042 USD -1,767 17.93 Profit of 1,103 on sale
2025-11-04 BUY 80 11.600 11.220 11.258 USD 901 18.00
2025-10-31 SELL -231 12.210 11.480 11.553 USD -2,669 18.07 Profit of 1,505 on sale
2025-10-23 SELL -78 15.880 15.930 15.925 USD -1,242 18.16 Profit of 175 on sale
2025-10-22 BUY 154 15.460 16.350 16.261 USD 2,504 18.18
2025-10-20 BUY 78 15.690 15.740 15.735 USD 1,227 18.20
2025-10-16 BUY 78 14.610 14.880 14.853 USD 1,159 18.24
2025-09-25 BUY 584 13.180 13.730 13.675 USD 7,986 18.51
2025-06-27 SELL -152 12.290 12.420 12.407 USD -1,886 19.57 Profit of 1,089 on sale
2025-06-12 BUY 225 12.690 13.090 13.050 USD 2,936 20.08
2025-06-10 SELL -1,184 13.980 14.410 14.367 USD -17,011 20.18 Profit of 6,883 on sale
2025-06-09 SELL -1,406 13.880 14.280 14.240 USD -20,021 20.23 Profit of 8,421 on sale
2025-05-30 SELL -146 12.660 12.820 12.804 USD -1,869 20.58 Profit of 1,136 on sale
2025-05-19 BUY 73 13.550 13.620 13.613 USD 994 21.20
2025-05-09 SELL -405 12.250 12.890 12.826 USD -5,195 21.64 Profit of 3,571 on sale
2025-04-23 SELL -79 16.260 17.260 17.160 USD -1,356 22.42 Profit of 415 on sale
2025-04-17 SELL -78 15.830 15.960 15.947 USD -1,244 22.71 Profit of 528 on sale
2025-04-10 BUY 608 17.420 19.130 18.959 USD 11,527 23.07
2025-04-04 SELL -152 19.570 19.860 19.831 USD -3,014 23.26 Profit of 521 on sale
2025-04-02 SELL -152 21.780 21.880 21.870 USD -3,324 23.27 Profit of 214 on sale
2025-03-31 SELL -228 21.990 22.270 22.242 USD -5,071 23.31 Profit of 244 on sale
2025-03-19 SELL -74 22.820 22.950 22.937 USD -1,697 23.42 Profit of 36 on sale
2025-02-28 SELL -146 23.210 23.250 23.246 USD -3,394 23.58 Profit of 49 on sale
2025-02-05 BUY 228 26.550 26.610 26.604 USD 6,066 23.41
2025-02-04 BUY 304 26.050 26.310 26.284 USD 7,990 23.35
2025-01-29 SELL -76 26.120 26.410 26.381 USD -2,005 23.05 Loss of -253 on sale
2025-01-23 SELL -76 25.600 25.610 25.609 USD -1,946 22.71 Loss of -221 on sale
2025-01-02 SELL -146 23.020 23.200 23.182 USD -3,385 22.70 Loss of -71 on sale
2024-12-04 BUY 219 24.110 24.920 24.839 USD 5,440 22.45
2024-12-03 SELL -73 24.630 24.790 24.774 USD -1,809 22.37 Loss of -176 on sale
2024-12-02 SELL -876 24.580 24.650 24.643 USD -21,587 22.28 Loss of -2,070 on sale
2024-11-29 SELL -1,480 24.580 24.870 24.841 USD -36,765 22.19 Loss of -3,926 on sale
2024-11-27 SELL -222 24.540 24.560 24.558 USD -5,452 21.98 Loss of -571 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-06	SELL	-160	11.330	11.010	11.042	USD -1,767	17.93 Profit of 1,103 on sale
2025-11-04	BUY	80	11.600	11.220	11.258	USD 901	18.00
2025-10-31	SELL	-231	12.210	11.480	11.553	USD -2,669	18.07 Profit of 1,505 on sale
2025-10-23	SELL	-78	15.880	15.930	15.925	USD -1,242	18.16 Profit of 175 on sale
2025-10-22	BUY	154	15.460	16.350	16.261	USD 2,504	18.18
2025-10-20	BUY	78	15.690	15.740	15.735	USD 1,227	18.20
2025-10-16	BUY	78	14.610	14.880	14.853	USD 1,159	18.24
2025-09-25	BUY	584	13.180	13.730	13.675	USD 7,986	18.51
2025-06-27	SELL	-152	12.290	12.420	12.407	USD -1,886	19.57 Profit of 1,089 on sale
2025-06-12	BUY	225	12.690	13.090	13.050	USD 2,936	20.08
2025-06-10	SELL	-1,184	13.980	14.410	14.367	USD -17,011	20.18 Profit of 6,883 on sale
2025-06-09	SELL	-1,406	13.880	14.280	14.240	USD -20,021	20.23 Profit of 8,421 on sale
2025-05-30	SELL	-146	12.660	12.820	12.804	USD -1,869	20.58 Profit of 1,136 on sale
2025-05-19	BUY	73	13.550	13.620	13.613	USD 994	21.20
2025-05-09	SELL	-405	12.250	12.890	12.826	USD -5,195	21.64 Profit of 3,571 on sale
2025-04-23	SELL	-79	16.260	17.260	17.160	USD -1,356	22.42 Profit of 415 on sale
2025-04-17	SELL	-78	15.830	15.960	15.947	USD -1,244	22.71 Profit of 528 on sale
2025-04-10	BUY	608	17.420	19.130	18.959	USD 11,527	23.07
2025-04-04	SELL	-152	19.570	19.860	19.831	USD -3,014	23.26 Profit of 521 on sale
2025-04-02	SELL	-152	21.780	21.880	21.870	USD -3,324	23.27 Profit of 214 on sale
2025-03-31	SELL	-228	21.990	22.270	22.242	USD -5,071	23.31 Profit of 244 on sale
2025-03-19	SELL	-74	22.820	22.950	22.937	USD -1,697	23.42 Profit of 36 on sale
2025-02-28	SELL	-146	23.210	23.250	23.246	USD -3,394	23.58 Profit of 49 on sale
2025-02-05	BUY	228	26.550	26.610	26.604	USD 6,066	23.41
2025-02-04	BUY	304	26.050	26.310	26.284	USD 7,990	23.35
2025-01-29	SELL	-76	26.120	26.410	26.381	USD -2,005	23.05 Loss of -253 on sale
2025-01-23	SELL	-76	25.600	25.610	25.609	USD -1,946	22.71 Loss of -221 on sale
2025-01-02	SELL	-146	23.020	23.200	23.182	USD -3,385	22.70 Loss of -71 on sale
2024-12-04	BUY	219	24.110	24.920	24.839	USD 5,440	22.45
2024-12-03	SELL	-73	24.630	24.790	24.774	USD -1,809	22.37 Loss of -176 on sale
2024-12-02	SELL	-876	24.580	24.650	24.643	USD -21,587	22.28 Loss of -2,070 on sale
2024-11-29	SELL	-1,480	24.580	24.870	24.841	USD -36,765	22.19 Loss of -3,926 on sale
2024-11-27	SELL	-222	24.540	24.560	24.558	USD -5,452	21.98 Loss of -571 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of IART

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	200,860	0	342,324	58.7%
2025-09-18	245,523	0	426,036	57.6%
2025-09-17	219,298	0	308,535	71.1%
2025-09-16	189,736	0	339,123	55.9%
2025-09-15	311,405	0	512,195	60.8%
2025-09-12	205,909	0	320,823	64.2%
2025-09-11	350,439	0	718,800	48.8%
2025-09-10	247,943	0	396,708	62.5%
2025-09-09	260,941	0	485,210	53.8%
2025-09-08	306,988	528	453,325	67.7%
2025-09-05	346,937	0	460,014	75.4%
2025-09-04	398,359	0	759,826	52.4%
2025-09-03	485,867	0	778,196	62.4%
2025-09-02	231,976	0	373,414	62.1%
2025-08-29	417,210	981	707,670	59.0%
2025-08-28	323,733	0	583,378	55.5%
2025-08-27	557,498	807	1,292,647	43.1%
2025-08-26	315,944	0	528,778	59.7%
2025-08-25	317,205	0	482,389	65.8%
2025-08-22	382,724	0	717,891	53.3%
2025-08-21	178,737	0	284,394	62.8%
2025-08-20	341,582	31	691,272	49.4%
2025-08-19	368,719	0	685,728	53.8%
2025-08-18	371,715	0	701,232	53.0%
2025-08-15	327,206	0	620,445	52.7%
2025-08-14	241,966	0	473,349	51.1%
2025-08-13	265,549	526	710,399	37.4%
2025-08-12	269,644	0	810,623	33.3%
2025-08-11	306,600	0	800,147	38.3%
2025-08-08	362,062	300	898,715	40.3%
2025-08-07	382,300	0	998,598	38.3%
2025-08-06	441,392	53	927,921	47.6%
2025-08-05	491,034	0	872,429	56.3%
2025-08-04	313,621	66,725	657,282	47.7%
2025-08-01	645,719	40,049	960,271	67.2%
2025-07-31	937,686	0	1,264,837	74.1%
2025-07-30	268,419	0	456,370	58.8%
2025-07-29	234,719	0	447,928	52.4%
2025-07-28	285,598	0	597,581	47.8%
2025-07-25	215,394	110	504,276	42.7%
2025-07-24	244,699	0	492,635	49.7%
2025-07-23	221,784	0	517,973	42.8%
2025-07-22	184,579	787	359,377	51.4%
2025-07-21	203,160	0	367,500	55.3%
2025-07-18	187,790	0	327,248	57.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares US Medical Devices UCITS ETF
Issuer	Blackrock
Entity holding fund	iShares V Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300QETNU1W5JY7Z94
ETF Ticker	UMDV.AS(USD) CXE
ETF Ticker	UMDV(USD) Euronext Amsterdam